Stay updated on Pembrolizumab in Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Biliary Tract Cancer Clinical Trial page

  1. Check
    8 days ago
    No Change Detected
  2. Check
    15 days ago
    No Change Detected
  3. Check
    23 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:55:19.000Z thumbnail image
  4. Check
    44 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T22:00:51.000Z thumbnail image
  5. Check
    72 days ago
    Change Detected
    Summary
    Revision number updated to v3.3.2, replacing the previous v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:40:02.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    Removed the banner warning about government funding potentially affecting up-to-date information and NIH Clinical Center operating status; no trial data or eligibility details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T06:54:38.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    The update appears to be formatting changes to the Study Details page without altering core trial information (eligibility criteria, endpoints, status, or enrollment); these differences are cosmetic and do not modify the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:53:00.000Z thumbnail image
  8. Check
    123 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    4%
    Check dated 2025-10-06T05:11:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.